- Home
- IMAB vs MASS Comparison
IMAB vs MASS Comparison
Compare IMAB & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- MASS
- Stock Information
- Founded
- IMAB 2014
- MASS 2012
- Country
- IMAB United States
- MASS United States
- Employees
- IMAB N/A
- MASS N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- MASS Medical/Dental Instruments
- Sector
- IMAB Health Care
- MASS Health Care
- Exchange
- IMAB Nasdaq
- MASS Nasdaq
- Market Cap
- IMAB 83.8M
- MASS 77.0M
- IPO Year
- IMAB 2020
- MASS 2020
- Fundamental
- Price
- IMAB $0.94
- MASS $2.09
- Analyst Decision
- IMAB Strong Buy
- MASS Buy
- Analyst Count
- IMAB 3
- MASS 3
- Target Price
- IMAB $8.00
- MASS $8.00
- AVG Volume (30 Days)
- IMAB 288.7K
- MASS 252.2K
- Earning Date
- IMAB 08-28-2024
- MASS 11-12-2024
- Dividend Yield
- IMAB N/A
- MASS N/A
- EPS Growth
- IMAB N/A
- MASS N/A
- EPS
- IMAB N/A
- MASS N/A
- Revenue
- IMAB $3,313,984.00
- MASS $55,162,000.00
- Revenue This Year
- IMAB N/A
- MASS $15.31
- Revenue Next Year
- IMAB N/A
- MASS $16.10
- P/E Ratio
- IMAB N/A
- MASS N/A
- Revenue Growth
- IMAB N/A
- MASS 16.08
- 52 Week Low
- IMAB $0.90
- MASS $2.00
- 52 Week High
- IMAB $2.54
- MASS $12.51
- Technical
- Relative Strength Index (RSI)
- IMAB 38.29
- MASS 34.25
- Support Level
- IMAB $0.91
- MASS $2.01
- Resistance Level
- IMAB $1.11
- MASS $2.32
- Average True Range (ATR)
- IMAB 0.07
- MASS 0.17
- MACD
- IMAB -0.00
- MASS -0.02
- Stochastic Oscillator
- IMAB 13.01
- MASS 5.76
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.